BlackRock, Inc. 13D and 13G filings for CLOVIS ONCOLOGY INC:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-07-08 4:56 pm Sale |
2022-06-30 | 13G | CLOVIS ONCOLOGY INC CLVSQ |
BlackRock Inc. BLK |
4,755,365 3.300% |
-4,995,912 (-51.23%) |
Filing |
| 2022-03-11 2:13 pm Unchanged |
2021-12-31 | 13G | CLOVIS ONCOLOGY INC CLVSQ |
BlackRock Inc. BLK |
9,751,277 7.500% |
0 (Unchanged) |
Filing |
| 2022-02-08 5:05 pm Purchase |
2021-12-31 | 13G | CLOVIS ONCOLOGY INC CLVSQ |
BlackRock Inc. BLK |
9,751,277 7.500% |
2,890,045 (+42.12%) |
Filing |
| 2021-02-05 07:51 am Purchase |
2020-12-31 | 13G | CLOVIS ONCOLOGY INC CLVSQ |
BlackRock Inc. BLK |
6,861,232 7.800% |
3,210,545 (+87.94%) |
Filing |